Clinical Trials on 副甲状腺機能亢進症;二次、腎臓 in Japan
合計266件
-
Astellas Pharma Inc完了
-
Pfizer's Upjohn has merged with Mylan to form Viatris...終了しました
-
Institute for Health Outcomes and Process Evaluation...完了
-
Otsuka Pharmaceutical Co., Ltd.完了
-
Telix International Pty Ltd完了
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd完了
-
Daiichi Sankyo Co., Ltd.完了
-
Astellas Pharma Inc完了
-
Mitsubishi Tanabe Pharma Corporation完了
-
KVT-Study GroupYokohama City University; Showa University; Kitasato University; St. Marianna University School... と他の協力者完了
-
Kissei Pharmaceutical Co., Ltd.完了Chronic Kidney Disease Requiring Hemodialysis日本
-
Astellas Pharma Inc完了Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis日本
-
Hamamatsu Universityわからない
-
CANDLE-KIT Trial Study GroupChugai Pharmaceutical; Roche Diagnostics; The Japan Kidney Foundation; Japanese Society for the...終了しました腎不全、慢性 | 貧血 | ビタミンD欠乏症 | 腎臓移植日本
-
Bayer完了
-
National Center of Neurology and Psychiatry, Japan完了
-
Translational Research Center for Medical Innovation...Showa University School of Medicine完了
-
Osaka UniversityBayer招待による登録
-
Toray Industries, IncAstellas Pharma Inc完了
-
Kyushu UniversityMerck Sharp & Dohme LLC完了